A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

It’s time to step up the opposition to designer babies, says Marcy Darnovsky of the Center for Genetics and Society ...

Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient ...

UC Berkeley and Caltech researchers identified a gene circuit in zebrafish that allows heart regeneration after injury. Using ...

CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.